Videos
Articles
Citations: 492
The EAACI/GA(2)LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update
Zuberbier, T. et al.
Citations: 291
EAACI Food Allergy and Anaphylaxis Guidelines: diagnosis and management of food allergy
Muraro, A. et al.
Citations: 256
Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology
Muraro, A. et al.
Citations: 153
EAACI Food Allergy and Anaphylaxis Guidelines. Primary prevention of food allergy
Muraro, A. et al.
Citations: 112
Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI Position Paper
Pfaar, O. et al.
Citations: 69
MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation
Bousquet, J. et al.
Letter to the Editor
Allergenomics of the tick Ixodes ricinus reveal important α‐Gal‐carrying IgE‐binding proteins in red meat allergy
Danijela Apostolovic et al.
News & Views: Recent Patents in Allergy and Immunology
Treatment of allergic disease with nanoemulsion adjuvant vaccines
Jessica J. O'Konek et al.
Letter to the Editor
Factors associated with well‐controlled asthma – a cross‐sectional study
Helena Lindgren et al.
Letter to the Editor
Antimicrobial peptide derived from insulin‐like growth factor‐binding protein 5 activates mast cells via Mas‐related G protein‐coupled receptor X2
François Niyonsaba et al.
Original Article: Airway Diseases
Evidence for the induction of Th2 inflammation by group 2 innate lymphoid cells in response to prostaglandin D2 and cysteinyl leukotrienes in allergic rhinitis
Ichiro Tojima et al.
Editorial
Allergen‐specific immunotherapy: power of adjuvants and novel predictive biomarkers
Milena Sokolowska et al.
Original Article: Skin and Eye Diseases
Vemurafenib acts as an aryl hydrocarbon receptor antagonist: Implications for inflammatory cutaneous adverse events
Heike C. Hawerkamp et al.
Original Article: Asthma and Lower Airway Disease
Risk of adult‐onset asthma increases with the number of allergic multimorbidities and decreases with age
Sanna Toppila‐Salmi et al.
Junior Members Corner
EAACI JMs come from all corners of the globe, and have been making significant contributions to the field of allergy. Read about some of their accolades here!
Meet a New JM Representative
Today we get to spend some time with Dr. Leticia De las Vecillas, the new elected JM Representative of the Allergy Diagnosis & Systems Medicine IG.
Dr. De las Vecillas was trained as allergist at Marqués de Valdecilla University Hospital (HUMV) in Santander (Spain). Her training included two internships at Gregorio Marañón University Hospital in Madrid (Spain). Right after, she joined the Brigham and Women’s Hospital (Boston, MA), where she participated in patient desensitization to drugs and performed basic research on mast cell desensitization via the human receptor FcεRI.
Dr. De las Vecillas is currently a clinician-scientist at HUMV. Here she leads the Drug Desensitization program and an immunology group focused on drug diagnostic tests and new biomarkers in patients undergoing desensitization. In addition, she is completing her PhD training on Anisakis simplex allergy.
Dr. De las Vecillas was trained as allergist at Marqués de Valdecilla University Hospital (HUMV) in Santander (Spain). Her training included two internships at Gregorio Marañón University Hospital in Madrid (Spain). Right after, she joined the Brigham and Women’s Hospital (Boston, MA), where she participated in patient desensitization to drugs and performed basic research on mast cell desensitization via the human receptor FcεRI.
Dr. De las Vecillas is currently a clinician-scientist at HUMV. Here she leads the Drug Desensitization program and an immunology group focused on drug diagnostic tests and new biomarkers in patients undergoing desensitization. In addition, she is completing her PhD training on Anisakis simplex allergy.
Image: Dr. Leticia De las Vecillas, new JM Representative of the Allergy Diagnosis & Systems Medicine IG.
Image: Marqués de Valdecilla University Hospital (HUMV) in Santander (Spain).
Image: Dr. De las Vecillas with her colleagues at HUMV.
Time Travel!
Let’s travel in time, back to the year 2001!
Who was part of the JMA board chaired by Susanna Olsson from 2001-2003? What kind of professional endeavours were taken by this line-up of JMs since then?
Well, here are some facts that you may find interesting:
- Iona Agache, our past EAACI President, was the Webmaster, and Stefano del Giacco, our current EAACI VP Education & Specialty, was the Immunology Section Representative.
- A young postdoctoral fellow that later would shake the field of immunology with seminal discoveries was the Asthma Section Representative. Can you guess who? You may have read his recent publication on Charcot-Leyden crystals... And he is a full professor at Ghent University (Belgium), like Philippe Gevaert, the ENT Section Representative at the time.
- The Dermatology Section Representative, Ulrike Raap, kept her scientific interests and is currently the Head of the Experimental Allergology and Immunodermatology Division at Oldenburg University (Germany). Likewise, Katharina Blumchen, the Pediatric Section Representative, is now affiliated with the Dept. of Children and Adolescent Medicine at the University Hospital Frankfurt (Germany).
Given that the JMs represent the future of EAACI, it is certainly encouraging to see that many of the leaders in the field that we now look up to, were once, not that long ago, part of the JMA.
Who was part of the JMA board chaired by Susanna Olsson from 2001-2003? What kind of professional endeavours were taken by this line-up of JMs since then?
Well, here are some facts that you may find interesting:
- Iona Agache, our past EAACI President, was the Webmaster, and Stefano del Giacco, our current EAACI VP Education & Specialty, was the Immunology Section Representative.
- A young postdoctoral fellow that later would shake the field of immunology with seminal discoveries was the Asthma Section Representative. Can you guess who? You may have read his recent publication on Charcot-Leyden crystals... And he is a full professor at Ghent University (Belgium), like Philippe Gevaert, the ENT Section Representative at the time.
- The Dermatology Section Representative, Ulrike Raap, kept her scientific interests and is currently the Head of the Experimental Allergology and Immunodermatology Division at Oldenburg University (Germany). Likewise, Katharina Blumchen, the Pediatric Section Representative, is now affiliated with the Dept. of Children and Adolescent Medicine at the University Hospital Frankfurt (Germany).
Given that the JMs represent the future of EAACI, it is certainly encouraging to see that many of the leaders in the field that we now look up to, were once, not that long ago, part of the JMA.
